Use of Antiplatelet Agents and Anticoagulants in Post-Myocardial Infarction
- 1 August 1994
- journal article
- review article
- Published by Elsevier in Cardiology Clinics
- Vol. 12 (3), 451-476
- https://doi.org/10.1016/s0733-8651(18)30094-8
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Current Medical and Surgical Therapy for Cerebrovascular DiseaseNew England Journal of Medicine, 1987
- Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study.Circulation, 1985
- Aspirin in the Prevention of Myocardial Infarction Current StatusDrugs, 1984
- A Controlled Comparison of Aspirin and Oral Anticoagulants in Prevention of Death after Myocardial InfarctionNew England Journal of Medicine, 1982
- The Anturane Reinfarction Trial: Reevaluation of OutcomeNew England Journal of Medicine, 1982
- Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial InfarctionNew England Journal of Medicine, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1977